Search clinical trials for: Ruxolitinib Phosphate Cream
Total 5274 results
-
Incyte CorporationCompletedA Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic DermatitisAtopic DermatitisUnited States, Canada
-
Tufts Medical CenterCompleted
-
Incyte CorporationInnovaderm ResearchCompleted
-
Incyte CorporationRecruitingPrurigoUnited States, Spain, France, Poland, Germany, Belgium, Netherlands, Argentina, Italy, Canada, Chile, Brazil
-
Incyte CorporationCompletedAtopic DermatitisUnited States
-
Incyte CorporationRecruitingPrurigo NodularisKorea, Republic of, Spain, United States, Poland, Italy, Australia, Austria, Germany, Canada, Switzerland, France, Denmark, Bulgaria
-
Incyte CorporationCompleted
-
Incyte CorporationRecruitingAtopic DermatitisGermany, Poland, United States, Spain, United Kingdom, Italy, Belgium, Canada, Netherlands, Australia, Bulgaria, France, Switzerland, Hungary, Korea, Republic of
-
Incyte CorporationCompletedAtopic DermatitisUnited States, France, Canada, Hungary, Poland, Germany, Italy
-
Incyte CorporationCompletedAtopic DermatitisUnited States, Germany, Spain, Canada, Poland, Czechia, Bulgaria
-
Incyte CorporationTerminatedAlopecia AreataUnited States
-
Incyte CorporationCompletedCutaneous Lichen PlanusUnited States, Canada
-
Incyte CorporationCompletedHidradenitis SuppurativaUnited States, Canada
-
Incyte CorporationCompletedLichen SclerosusUnited States, Canada
-
University of ZurichIncyte CorporationNot yet recruitingExanthema | Lichenoid Skin Rashes Under Anti-PD1 Tumor Therapy
-
Incyte CorporationRecruitingPrurigo NodularisUnited States
-
Milton S. Hershey Medical CenterIncyte CorporationRecruitingHidradenitis SuppurativaUnited States
-
Incyte CorporationActive, not recruitingA Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital VitiligoNonsegmental Vitiligo With Genital InvolvementCanada, United States, France
-
Icahn School of Medicine at Mount SinaiIncyte CorporationCompleted
-
Incyte CorporationRecruiting
-
Incyte CorporationCompleted
-
Incyte CorporationCompletedAtopic DermatitisUnited States
-
Incyte CorporationCompletedAtopic DermatitisUnited States, Canada
-
Incyte CorporationCompletedVitiligoUnited States, Canada, Poland, Spain, Germany, Bulgaria, France, Netherlands
-
Incyte CorporationCompleted
-
Memorial Sloan Kettering Cancer CenterIncyte Corporation; Hackensack Meridian HealthCompletedNon-sclerotic Cutaneous Chronic Graft-versus-host DiseaseUnited States
-
Incyte CorporationCompletedVitiligoUnited States, Canada, France
-
Incyte CorporationActive, not recruitingAtopic Dermatitis (AD)Canada, United States, Poland
-
Incyte CorporationActive, not recruitingHand EczemaUnited States, Poland, Canada, Germany
-
Incyte CorporationWithdrawnHand EczemaUnited States, Germany, Spain, Czechia, Canada, Poland
-
Incyte CorporationWithdrawnChronic Hand Eczema (CHE)United States, Canada, Spain, Germany, Czechia, Poland, Bulgaria
-
Incyte CorporationCompletedNon-segmental VitiligoUnited States, Spain, Canada, France, Poland, Bulgaria, Germany, Italy
-
Incyte CorporationCompletedAtopic DermatitisUnited States, Canada
-
Incyte CorporationCompletedNon-segmental VitiligoUnited States, Canada, Italy, France, Germany, Spain, Poland, Bulgaria, Netherlands
-
National Institute of Arthritis and Musculoskeletal...TerminatedGraft Versus Host Disease | JNS Kinase | Topical AdministrationUnited States
-
Incyte CorporationRecruitingPregnancy Related | Atopic DermatitisUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic LeukemiaUnited States
-
University of NebraskaNational Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Mature T- and NK-Cell Non-Hodgkin LymphomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Incyte CorporationCompletedPsoriasisUnited States
-
Incyte CorporationCompletedVitiligoUnited States, Canada
-
OHSU Knight Cancer InstituteCompletedChronic Neutrophilic Leukemia | Atypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Untreated Chronic Lymphocytic LeukemiaUnited States
-
First Affiliated Hospital of Zhejiang UniversityXiangya Hospital of Central South University; Second Affiliated Hospital, School... and other collaboratorsRecruitingHematologic Malignancy | Bronchiolitis Obliterans SyndromeChina
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
Incyte CorporationActive, not recruiting
-
Julie NangiaIncyte Corporation; Translational Breast Cancer Research ConsortiumRecruitingDuctal Carcinoma In Situ | Atypical Ductal Hyperplasia | Atypical Lobular Hyperplasia | Lobular Carcinoma In SituUnited States
-
Graceway Pharmaceuticals, LLCCompletedGenital WartsUnited States
-
Beijing Friendship HospitalUnknownHemophagocytic LymphohistiocytosisChina
-
University of North Carolina, Chapel HillCompletedLaparoscopic Hysterectomy and/or Laparoscopic SacrocolpopexyUnited States